Effects and safety of atmospheric low-temperature plasma on bacterial reduction in chronic wounds and wound size reduction: A systematic review and meta-analysis.

atmospheric low-temperature plasma bacterial reduction cold atmospheric plasma infection physical plasma wound wound healing wound tolerability

Journal

International wound journal
ISSN: 1742-481X
Titre abrégé: Int Wound J
Pays: England
ID NLM: 101230907

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 25 05 2018
accepted: 31 08 2018
pubmed: 13 10 2018
medline: 7 5 2019
entrez: 13 10 2018
Statut: ppublish

Résumé

The use of atmospheric low-temperature plasma (AP) on chronic wounds and its effect on microbial bioburden in open wounds has not been explored with a systematic review and meta-analysis. PRISMA guidelines were followed and PubMed, Embase, CENTRAL, and CINAHL databases searched for randomised controlled trials (RCTs), which compared AP with no AP for the management of open, chronic wounds. The primary outcomes of reduction of bioburden or wound size were included. Meta-analyses were performed; odds ratio (OR) and 95% confidence intervals (CIs) were extracted and pooled in a random effects model. Four RCTs investigated the effect of AP on chronic wound healing. Chronic wounds treated with AP did not show a significant improvement in healing (AP vs control: OR = 1.46; 95% CI = 0.89-2.38; P = 0.13). Five further RCTs investigated the reduction of bioburden in wounds, but AP demonstrated no significant reduction of bioburden (AP vs control: OR = 0.85; 95% CI = 0.45-1.62; P = 0.63). All nine RCTs recorded the presence of any severe adverse events (SAEs) in the 268 patients studied, with only one unrelated SAE identified in each group (AP vs control: OR = 1.00; 95% CI = 0.05-19.96; P = 1.00). Use of AP in wound care is safe, but the retrieved evidence and meta-analysis show that there is no clinical benefit of AP in chronic open wounds using currently available AP device settings.

Identifiants

pubmed: 30311743
doi: 10.1111/iwj.12999
pmc: PMC7379569
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-111

Informations de copyright

© 2018 The Authors. International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Références

Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
J Pediatr Surg. 2013 Jan;48(1):67-73
pubmed: 23331795
Biochim Biophys Acta. 2014 Dec;1843(12):2827-37
pubmed: 25173814
J Wound Care. 2013;22(5 Suppl):S1-89
pubmed: 24645204
Arch Biochem Biophys. 2016 Sep 1;605:3-10
pubmed: 27109191
BMC Cancer. 2012 Oct 15;12:473
pubmed: 23066891
Environ Sci Technol. 2005 Jan 1;39(1):339-44
pubmed: 15667115
PLoS One. 2013 May 21;8(5):e64498
pubmed: 23704990
Biosens Bioelectron. 2011 Oct 15;28(1):333-8
pubmed: 21820891
Int J Cancer. 2012 May 1;130(9):2185-94
pubmed: 21702038
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Br J Dermatol. 2012 Aug;167(2):404-10
pubmed: 22385038
Microvasc Res. 2016 Jul;106:8-13
pubmed: 26944583
J Am Acad Dermatol. 2017 Feb;76(2):349-350
pubmed: 28088998
J Eur Acad Dermatol Venereol. 2015 Jan;29(1):148-55
pubmed: 24666170
Wound Repair Regen. 2005 Jul-Aug;13(4):412-21
pubmed: 16008731
Int Wound J. 2019 Feb;16(1):103-111
pubmed: 30311743
Sci Rep. 2017 Apr 21;7(1):1027
pubmed: 28432354
Toxicol In Vitro. 2011 Mar;25(2):530-7
pubmed: 21111803
Biointerphases. 2015 Jun 08;10(2):029519
pubmed: 25956181
J Craniomaxillofac Surg. 2016 Sep;44(9):1445-52
pubmed: 27499516
Khirurgiia (Mosk). 1989 Jul;(7):94-6
pubmed: 2796203
J Wound Care. 2017 Jan 2;26(1):20-25
pubmed: 28103163
J Biophotonics. 2015 May;8(5):382-91
pubmed: 24659472
Arch Med Res. 2013 Apr;44(3):169-77
pubmed: 23506720
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Am J Gastroenterol. 2003 Jul;98(7):1610-5
pubmed: 12873587
J Wound Care. 2016 Mar;25(3 Suppl):S3-6
pubmed: 26949863
Wound Repair Regen. 2013 Nov-Dec;21(6):800-7
pubmed: 23937657
J Wound Care. 2015 May;24(5):196, 198-200, 202-3
pubmed: 25970756
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Int J Pharm. 2001 Sep 11;226(1-2):1-21
pubmed: 11532565
Br J Dermatol. 2010 Jul;163(1):78-82
pubmed: 20222930
J Eur Acad Dermatol Venereol. 2013 Mar;27(3):324-31
pubmed: 22188329
Ann Biomed Eng. 2011 Feb;39(2):674-87
pubmed: 21046465
Sci Rep. 2016 Oct 06;6:34419
pubmed: 27708352
PLoS One. 2014 Jun 27;9(6):e101299
pubmed: 24971517
Br J Cancer. 2011 Oct 25;105(9):1295-301
pubmed: 21979421
Mycoses. 2016 Jul;59(7):467-75
pubmed: 26932256
Am J Gastroenterol. 2006 Aug;101(8):1762-9
pubmed: 16817835
J Hosp Infect. 2003 Oct;55(2):108-15
pubmed: 14529634

Auteurs

Ojan Assadian (O)

Department for Hospital Epidemiology and Infection Control, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
Institute for Skin Integrity and Infection Prevention, University of Huddersfield, Huddersfield, UK.

Karen J Ousey (KJ)

Institute for Skin Integrity and Infection Prevention, University of Huddersfield, Huddersfield, UK.

George Daeschlein (G)

Department of Dermatology, University Medicine Greifswald, Greifswald, Germany.

Axel Kramer (A)

Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany.

Christina Parker (C)

School of Nursing, Queensland University of Technology, Brisbane, Australia.

Judith Tanner (J)

Division of Nursing, School of Health Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK.

David J Leaper (DJ)

Institute for Skin Integrity and Infection Prevention, University of Huddersfield, Huddersfield, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH